A strong correlation between plasma total cholesterol levels and atherosclerotic lesion area in the aortic root was observed, suggesting cholesterol lowering with a PCSK9 inhibitor itself leads to inhibition of atherosclerosis development and improves plaque morphology. This evidence concerns the gene PCSK9 and atherosclerosis.